Market Research Reports Global Multiplex Biomarker Imaging Market

Rapid Growth of Global Multiplex Biomarker Imaging Market
2019|Forecast to 2023
Global Multiplex Biomarker Imaging
Market report explores future trends for
supply, demand and market growth rate,
market size, prices, trading, competition
and value chain as well as Key Players of
the industry’s information with forecast
from 2019 to 2023.
Global Multiplex Biomarker Imaging Market Synopsis:
According to Market Analyst, the global multiplex biomarker imaging market is projected to expand at a
compound annual growth rate (CAGR) of 12.0% during the 2018–2023 period, generating a revenue of
USD 523.59 Mn by 2023.
The Global “Multiplex Biomarker Imaging Market” research 2019 highlights the major details and
provides in-depth analysis of the market along with the future growth, prospects and Industry demands
analysis explores with the help of complete report with 90 Pages, figures, graphs and table of contents
to analyze the situations of global Multiplex Biomarker Imaging Market and Assessment to 2023.
Get Exclusive Sample Study Papers of “Global Multiplex Biomarker Imaging Market” @
https://www.businessindustryreports.com/sample-request/174359 .
The global multiplex biomarker imaging market can be segmented based on:
1
Techniques - immunohistochemistry (IHC), fluorescence in situ hybridization (FISH),
immunofluorescence (IF), tissue microarray (TMA), and toponome imaging system (TIS)
2 Components - instruments, reagents and kits, and software
3 Applications - oncology studies, drug safety, genetic characterization, and others (neurodegeneration
and protein research)
4 End users - research institutes, translational labs, and pharma and biopharma companies
Based on Techniques, IHC held the largest market share (around 47%) in this segment in 2017. It is
widely used in research laboratories and clinical diagnostics, owing to the advantages it offers, vis-à-vis
traditional methods of enzyme staining, including specific antigen-antibody reactions. Higher incidence
of chronic diseases, especially cancer, is fuelling the need for targeted treatments, thereby contributing